Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Chiang Li
Sign up to set email alerts
57
Publications
583
Citation Statements Received
488
Citation Statements Given
How they've been cited
843
23
557
3
How they cite others
443
6
480
2
Affiliations
Boston Biomedical (United States)
,
La Trobe University
Publications
Order By: Most citations
Cancer Therapy with ß-Lapachone
Pardee
1
,
Li
2
,
Li
3
2002
CCDT
Abstract
Show
226
2
160
1
Get access via publisher
Add to collection
Cite
Pronounced acute immunosuppression
in vivo
mediated by HIV Tat challenge
Cohen
1
,
Li
2
,
Ding
3
et al.
1999
Proc. Natl. Acad. Sci. U.S.A.
Abstract
Show
88
3
48
1
Get access via publisher
Add to collection
Cite
A dose-escalation phase I study of a first-in-class cancer stemness inhibitor in patients with advanced malignancies.
Langleben
1
,
Supko
2
,
Hotte
3
et al.
2013
JCO
Abstract
Show
27
6
20
0
Get access via publisher
Add to collection
Cite
Phase Ib/II study of cancer stem cell (CSC) inhibitor BBI608 combined with paclitaxel in advanced gastric and gastroesophageal junction (GEJ) adenocarcinoma.
Becerra
1
,
Stephenson
2
,
Jonker
3
et al.
2015
JCO
31
0
25
0
Get access via publisher
Add to collection
Cite
Efficient intracellular delivery and multiple-target gene silencing triggered by tripodal RNA based nanoparticles: A promising approach in liver-specific RNAi delivery
Sajeesh
1
,
Lee
2
,
Kim
3
et al.
2014
Journal of Controlled Release
30
1
21
1
Get access via publisher
Add to collection
Cite
Phase 1b/2 trial of cancer stemness inhibitor napabucasin (NAPA) + nab-paclitaxel (nPTX) and gemcitabine (Gem) in metastatic pancreatic adenocarcinoma (mPDAC).
Bekaii‐Saab
1
,
Starodub
2
,
El‐Rayes
3
et al.
2018
JCO
17
2
20
0
Get access via publisher
Add to collection
Cite
BBI608-224: A phase Ib/II study of cancer stemness inhibitor napabucasin (BBI-608) administered with panitumumab in KRAS wild-type patients with metastatic colorectal cancer.
Larson
1
,
Ortuzar
2
,
Bekaii‐Saab
3
et al.
2017
JCO
Abstract
Show
12
2
17
0
Get access via publisher
Add to collection
Cite
Long dsRNA-Mediated RNA Interference and Immunostimulation: A Targeted Delivery Approach Using Polyethyleneimine Based Nano-Carriers
Sajeesh
1
,
Lee
2
,
Hong
3
et al.
2014
Mol. Pharmaceutics
Abstract
Show
23
0
19
0
Get access via publisher
Add to collection
Cite
1
2
3
4
5
6